QCLS — Q/C TECHNOLOGIES, INC.
—
Nasdaq ·
Health Care ·
Life Sciences Tools & Services ·
CIK 1321834 ·
Last close
$0.33
Market Cap
$2.74M
52W High
$8.17
52W Low
$0.28
ADV30
325,752
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 0 | 0 | -3,612,737 | -6,616,236 | 22,865,754 | 307,612 | 6,774,857 |
| Mar 2026 | 0 | 0 | -1,855,193 | -1,242,777 | 38,291,383 | 1,127,619 | 17,571,777 |
| Dec 2025 | 0 | 0 | -3,714,248 | -5,894,796 | 41,166,096 | 986,996 | 19,414,421 |
| Sep 2025 | 0 | 0 | -1,524,235 | -2,811,388 | 37,231,786 | 6,904,185 | 22,911,396 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-9,465,108
Investing CF
$-9,149,688
Financing CF
$18,714,855
CapEx
—
Dividends Paid
$-190,870
Buybacks
$0
EPS Diluted TTM
$-91.13
As of
2026-11-15
Balance + Analyst (yfinance extras)
Retained Earnings
$-152,190,703
Inventory
—
Receivables
$16,800
ST Investments
$10,679,782
EBIT TTM
$-10,706,413
Pretax Income TTM
$-16,565,197
Interest Exp TTM
—
Analysts
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 0 | -9,582,940 | -11,627,122 | 41,166,096 | 19,414,421 | 21,751,675 | -9,065,619 |
| Dec 2024 | 0 | -8,660,188 | -23,359,334 | 21,421,084 | 11,631,344 | 9,789,740 | -8,976,347 |
| Dec 2023 | 0 | -16,360,218 | -3,999,950 | 17,862,270 | 5,492,698 | 12,369,572 | -12,980,625 |
| Dec 2022 | 0 | -15,282,763 | -15,197,336 | 17,539,980 | 2,844,924 | 14,695,056 | -12,270,068 |
TTM Snapshot
Revenues TTM
$2,071,603
NetIncome TTM
$-16,565,197
OpCashFlow TTM
—
Assets (Latest)
$22,865,754
Forward EPS
—
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| BUDZ | WEED, INC. | $2.97M | $0.02 | — |
| BIAF | bioAffinity Technologies, Inc. | $2.48M | $1.93 | — |
| NYMXF | NYMOX PHARMACEUTICAL CORP | $3.15M | $0.03 | — |
| VSBC | VITASPRING BIOMEDICAL CO. LTD. | $3.21M | $0.02 | — |
| CBIH | Cannabis Bioscience International Holdings, Inc. | $1.74M | $0.00 | — |
News headlines (Yahoo Finance, 1h cache)
Q/C Technologies Reports Over $10 Million in Cash and Investments to Fund Development of Its Optical Processing Unit
2026-11-16 14:15 · Yahoo
Q/C Technologies Announces Research Collaboration with Sandia National Laboratories, a $5 Billion U.S. Department of Energy Lab
2026-10-01 18:43 · Yahoo
Q/C Technologies Relocates Headquarters to San Francisco in Proximity to World-Class Engineering Experts for Photonic Computing and Optical AI Inference Initiative
2026-07-01 13:44 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.